 Jennifer S Hreno
| Title | Senior Instructor |
|---|
| Institution | University of Colorado Denver - Anschutz Medical Campus |
|---|
| Department | SOM-MED |
|---|
| Phone | 720/848-0657 |
|---|
|
|
|
 Bibliographic
-
Cohen RB, Jimeno A, Hreno J, Sun L, Wall?n-?hman M, Millrud CR, Sanfridson A, Garcia-Ribas I. Safety, tolerability, and preliminary efficacy of nadunolimab, an anti-IL- 1 receptor accessory protein monoclonal antibody, in combination with pembrolizumab in patients with solid tumors. Invest New Drugs. 2025 May 01. PMID: 40310569.
-
Agrawal VR, Hreno J, Patil T, Bowles DW. New therapies for anaplastic thyroid cancer. Drugs Today (Barc). 2018 Nov; 54(11):695-704. PMID: 30539168.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
| Year | Publications |
|---|
| 2018 | 1 | | 2025 | 1 |
To return to the timeline, click here.
|
Hreno's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|